Business Description
Decoy Therapeutics Inc. is a Cambridge, Massachusetts-based drug development company that uses its proprietary IMP3ACT platform to design and produce peptide conjugate treatments for serious conditions such as infectious diseases and cancer. The platform combines artificial intelligence with advanced chemistry techniques to simplify the process of creating new medicines. The company was previously called Salarius Pharmaceuticals Inc. before renaming itself in January 2026.
